It will cover the mechanisms of Chk2 action, the role of Chk2 inhibitors in cancer treatment, their protective effects on non-cancerous cells during cancer therapy, and their therapeutic potential in treating HCV infections and neurodegenerative diseases. Here, CHEK2 is linked to neurodegenerative disease.